qsymiapharmacyenrollment.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Risk Evaluation and Mitigation Strategy (REMS) | Qsymia® (phentermine and topiramate |
| Description | Important Safety Information | Full Prescribing Information | Medication Guide Risk Evaluation and Mitigation Strategy (REMS) Home Pharmacy Training Progr |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 107.154.106.156 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
qsymiapharmacyenrollment.com Valuation
|
US$682
Last updated: 2023-05-15 10:47:13
qsymiapharmacyenrollment.com has Semrush global rank of 0. qsymiapharmacyenrollment.com has an estimated worth of US$ 682, based on its estimated Ads revenue. qsymiapharmacyenrollment.com receives approximately 78 unique visitors each day. Its web server is located in United States, with IP address 107.154.106.156. According to SiteAdvisor, qsymiapharmacyenrollment.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$682 |
| Daily Ads Revenue | US$0 |
| Monthly Ads Revenue | US$18 |
| Yearly Ads Revenue | US$226 |
| Daily Unique Visitors | 5 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| qsymiapharmacyenrollment.com. 3598 IN | A | IP: 107.154.106.156 | |
| qsymiapharmacyenrollment.com. 3598 IN | A | IP: 107.154.105.156 | |
| qsymiapharmacyenrollment.com. 3600 IN | NS | NS Record: ns26.domaincontrol.com. | |
| qsymiapharmacyenrollment.com. 3600 IN | NS | NS Record: ns25.domaincontrol.com. | |
| qsymiapharmacyenrollment.com. 3600 IN | MX | MX Record: 10 mailstore1.secureserver.net. | |
| qsymiapharmacyenrollment.com. 3600 IN | MX | MX Record: 0 smtp.secureserver.net. | |
| qsymiapharmacyenrollment.com. 3600 IN | TXT | TXT Record: _globalsign-domain-verification=uUOr1dzC48XJHJPDgEJd1QwM5kdkah5N4YXHRaDF8R |
HtmlToTextCheckTime:2023-05-15 10:47:13
| Important Safety Information | Full Prescribing Information | Medication Guide Risk Evaluation and Mitigation Strategy (REMS) Home Pharmacy Training Program Information for Pharmacists Qsymia Certified Pharmacy Network Risk of Birth Defects Patient Brochure Risk Evaluation and Mitigation Strategy (REMS) A Risk Evaluation and Mitigation Strategy (REMS) is a strategy to manage known or potential serious risks associated with a drug product and is required by the Food and Drug Administration (FDA) to ensure that the benefits of a drug outweigh its risks. The FDA has required a REMS for Qsymia. The purpose of the Qsymia REMS is to inform certified pharmacies and patients of reproductive potential about the: Increased risk of congenital malformation, specifically orofacial clefts, in infants exposed to Qsymia during the first trimester of pregnancy Importance of pregnancy prevention for patients of reproductive potential receiving Qsymia Need to discontinue Qsymia immediately if pregnancy |
HTTP Headers
HTTP/1.1 302 Found : Moved Temporarily
Location: https://qsymiapharmacyenrollment.com/
Connection: close
Cache-Control: no-cache
Pragma: no-cache
Set-Cookie: visid_incap_1077420=ZhtjZX5rRlOtL4VAi2WC1Q4yzGEAAAAAQUIPAAAAAAAeh/GsVqJ15tu0BH3majjD; expires=Thu, 29 Dec 2022 06:26:14 GMT; HttpOnly; path=/; Domain=.qsymiapharmacyenrollment.com
Set-Cookie: incap_ses_1341_1077420=X+7/ZvfQvUgNUEustjCcEg4yzGEAAAAA6ht47d38wXBOD7tJY2QVng==; path=/; Domain=.qsymiapharmacyenrollment.com
Set-Cookie: ___utmvmfwBulIpLB=BvtIZICxlGW; path=/; Max-Age=900
Set-Cookie: ___utmvafwBulIpLB=PedtiWf; path=/; Max-Age=900
Set-Cookie: ___utmvbfwBulIpLB=eZb
XgTOQalm: FtP; path=/; Max-Age=900
X-CDN: Imperva
X-Iinfo: 14-166026132-166026133 NNNN CT(70 -1 0) RT(1640772110141 0) q(0 0 1 0) r(1 1) U6
HTTP/2 200
server: Oracle-iPlanet-Web-Server/7.0
date: Wed, 29 Dec 2021 10:01:50 GMT
content-type: text/html
last-modified: Sat, 07 Oct 2017 20:58:12 GMT
content-length: 642
etag: "282-59d93fe4"
accept-ranges: bytes
set-cookie: visid_incap_1077420=h9aUUtD5Sleg3kllmffuLw4yzGEAAAAAQUIPAAAAAAB06c8FPevyEXBslEkvgsoP; expires=Thu, 29 Dec 2022 06:26:14 GMT; HttpOnly; path=/; Domain=.qsymiapharmacyenrollment.com
set-cookie: incap_ses_1341_1077420=8mCtal7prB2wUEustjCcEg4yzGEAAAAATuYMD8ZOlPUcGH8KnaiIxw==; path=/; Domain=.qsymiapharmacyenrollment.com
x-cdn: Imperva
x-iinfo: 14-166026261-166026262 NNNN CT(69 145 0) RT(1640772110696 0) q(0 0 3 -1) r(3 3) U6
|
qsymiapharmacyenrollment.com Whois Information
Domain Name: QSYMIAPHARMACYENROLLMENT.COM Registry Domain ID: 1821421144_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-01-24T14:37:06Z Creation Date: 2013-08-12T22:20:51Z Registry Expiry Date: 2022-08-12T22:20:51Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS25.DOMAINCONTROL.COM Name Server: NS26.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-30T07:02:39Z <<< |